Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26F40C2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,404
Award facts
- Contract value 100% obligated
- $12,404.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $12,404.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for OmniPod 5 DexG7G6 Pods (Generation 5), 5-count units. This non-set-aside contract represents a competitively awarded task order with a completion date of February 5, 2026, and performance to be delivered from the prime contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., functions as a critical pharmaceutical distributor and healthcare solutions provider supplying medical products to federal government agencies, particularly those supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The OmniPod 5 diabetes management pods being procured under this task order represent specialized medical devices within the company's portfolio of brand-name and generic medications, vaccines, and medical supplies provided to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F40C2?
SPE2DR26F40C2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F40C2 worth?
The government has obligated $12,404 on SPE2DR26F40C2.
Is contract SPE2DR26F40C2 an order under another contract?
Yes. SPE2DR26F40C2 is a delivery order under SPE2DR25D1051, an indefinite delivery contract.
Was contract SPE2DR26F40C2 competed?
The extent of competition for SPE2DR26F40C2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award